Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Aisthesis Medical is revolutionizing acute and critical care with its AI-powered clinical decision support software, VIOSync. This platform aims to improve patient outcomes and optimize cost…

Aisthesis Medical is revolutionizing acute and critical care with its AI-powered clinical decision support software, VIOSync. This platform aims to improve patient outcomes and optimize cost…
Product: VIOSync — AI-powered clinical decision support with sepsis prediction (Sepsis Prediction Index)
Tech: Explainable AI, digital patient twins, multimodal data; HL7/FHIR interoperability
Founders: Ioannis Gkouzionis (Co‑founder & CEO), Vasileios (Vasilis) Dimakopoulos (Co‑founder & CSO)
Team size: About 9 employees
Funding: Reported external financing (~£900k reported) plus grants; disclosed total funding in evidence: USD 240,000 (last funding 2024-06-17)
Acute and critical care — early detection of patient deterioration including sepsis.
Medtech / Healthtech
240000.00
Disclosed total funding amount in evidence
£900,000
Reported by third‑party coverage as a funding event
Awarded a EUREKA Innowwide grant (non-dilutive support) to advance sepsis-prediction work
“Backers and supporters listed include Anthology Ventures, EIT Health, and accelerator programs; Dealroom reported a pre-seed round led by TwinPath Ventures”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week